Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Immunogen Inc (IMGN)

Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is AbbVie Stock a Buy Now?

The company is grappling with losing Humira's patent protection in 2023.

IMGN : 31.23 (unch)
CERE : 44.96 (+0.74%)
ABBV : 193.47 (-0.08%)
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why

The acquisition fills an immediate need with some extras to boot.

ABBV : 193.47 (-0.08%)
IMGN : 31.23 (unch)
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors

It's making a major acquisition to beef up a key area of its pipeline.

PFE : 29.42 (-0.81%)
ABBV : 193.47 (-0.08%)
IMGN : 31.23 (unch)
AbbVie Just Announced 2 Big Acquisitions: Is This Dividend King a No-Brainer Buy Right Now?

The big drugmaker went on a holiday shopping spree.

AGN.AX : 0.740 (-1.33%)
ABBV : 193.47 (-0.08%)
IMGN : 31.23 (unch)
CERE : 44.96 (+0.74%)
AbbVie's on an Acquisition Binge. Could Your Favorite Biotech Stock Be Next?

Here's what's attracting lucrative buyout offers from big pharmaceutical companies these days.

ABBV : 193.47 (-0.08%)
CERE : 44.96 (+0.74%)
IMGN : 31.23 (unch)
Is AbbVie Stock a Buy Now?

AbbVie's business could soon become more diversified.

AGN.AX : 0.740 (-1.33%)
ABBV : 193.47 (-0.08%)
IMGN : 31.23 (unch)
Why Abbvie Stock Popped Today

The company announces a major deal worth over $10 billion.

ABBV : 193.47 (-0.08%)
IMGN : 31.23 (unch)
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio

AbbVie is spending more than $10 billion to add a potential blockbuster cancer treatment as cheaper versions of the drugmaker’s all-time best seller, Humira, cut into sales

$SPX : 5,702.55 (-0.19%)
$DOWI : 42,063.36 (+0.09%)
$IUXX : 19,791.49 (-0.24%)
IMGN : 31.23 (unch)
ABBV : 193.47 (-0.08%)
ImmunoGen: Q3 Earnings Snapshot

ImmunoGen: Q3 Earnings Snapshot

IMGN : 31.23 (unch)
Pioneering the Path to Cure Cancer: 2023's Biotech Innovations

VANCOUVER – Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their “Cancer Moonshot” initiative, an ambitious plan to slash cancer rates in half within...

RY : 121.92 (-0.93%)
RY.TO : 165.30 (-0.98%)
ONCY : 0.9239 (-2.75%)
ONC.TO : 1.26 (-2.33%)
LLY : 921.49 (+0.70%)
IMGN : 31.23 (unch)
AZN : 78.38 (-0.66%)
MRK : 117.17 (-0.05%)

Barchart Exclusives

Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF?
Equity investors often overlook market seasonality. Unfortunately, seasonality is usually tied to future markets. However, there are instances where the seasonality of commodities can enhance an Exchange-Traded Fund (ETF). Two significant commodities are entering a seasonal buy that will impact an outperforming homebuilder ETF. The Federal Reserve (FED) appears ready to begin a new cycle of lower rates, which may catalyze this ETF seasonal pattern. Does Your Portfolio Have Room for a 79% 5-Year Track Record ETF? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar